# Ground Truth Medical Form (GTMF)

## Patient Information

- **Subject ID**: 9265
- **Admission ID**: 182223
- **Row ID**: 17028
- **Profile Type**: FULL

## Demographics

- **Age**: 71
- **Sex**: M
- **Date of Birth**: 2115-05-01
- **Ethnicity**: WHITE
- **Marital Status**: WIDOWED
- **Religion**: CATHOLIC
- **Insurance**: Medicare
- **Admission Type**: ELECTIVE
- **Admission Date**: 2186-07-18 10:30:00
- **Discharge Date**: 2186-07-19 13:00:00

## Medical History

Hypercholesterolemia, peripheral vascular disease, mastoid surgery. No history of coronary artery disease, transient ischemic attack, or cerebrovascular accident. Denied hypertension.

## Current Medications

- **Aspirin** | dosage: 325 mg | frequency: q. day
- **Plavix** | dosage: 75 mg | frequency: q. day
- **Lorazepam** | dosage: 0.5 mg | frequency: q.a.m. p.r.n.
- **Lipitor** | dosage: 20 mg | frequency: q.h.s.
- **Vitamin C**
- **Vitamin E**
- **DHEA**
- **Aspirin** | purpose: Antiplatelet therapy
- **Lipitor** | purpose: Lipid lowering
- **Plavix** | purpose: Antiplatelet therapy

## Discharge Medications

- **Plavix** | dosage: 75 mg | frequency: q. day
- **Aspirin** | dosage: 325 mg | frequency: q. day
- **Lipitor** | dosage: 20 mg | frequency: q. day
- **Ativan** | dosage: 0.5 mg | frequency: q.a.m. p.r.n.
- **Vitamin E**
- **Vitamin C**

## Diagnoses

- **Right internal carotid artery stenosis (95%)** | notes: Treated with stent placement; 20% residual stenosis
- **Peripheral vascular disease** | notes: History admitted by patient
- **Hypercholesterolemia** | notes: History admitted by patient
- **Right internal carotid artery disease, status post stent placement** | notes: No evidence for congestive heart failure; neurologically intact; hemodynamically stable

## Treatment Options

### Carotid artery stenting

**Details**: Stent placed in right internal carotid artery with 20% residual stenosis

### Right internal carotid artery stent placement

**Details**: Post-procedure monitoring for transient ischemic attacks and cerebrovascular accidents; maintain systolic blood pressure 140-170 mmHg for first week post-op; telemetry monitoring for bradycardias or vagal symptoms
**Treatment**: Continue Plavix and aspirin for nine months; continue Lipitor; oxygen weaned; fluid and electrolytes monitored and repleted

**Medications**:
- Plavix (75 mg)
- Aspirin (325 mg)
- Lipitor (20 mg)
- Ativan (0.5 mg)
- Vitamin E (not provided)
- Vitamin C (not provided)
